Real-time Experiences, Physical Activity and Biological Outcomes in Personal Recovery Residents (EMPOWER-RES)
Launched by IRCCS CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI · Mar 31, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The EMPOWER-RES trial is studying how different types of treatment can help people with severe mental disorders live better lives. It focuses on patients living in Italian mental health supported accommodations, where the goal is to support their personal recovery. The researchers want to see if using a special tool called the Mental Health Recovery Star, which helps patients track their progress in different areas of life, can lead to better outcomes compared to standard treatment methods.
To participate in this study, patients must be over 18, diagnosed with a mental disorder, and currently receiving treatment at one of the recruiting centers. They should also be able to speak and write in Italian. Caregivers and mental health professionals who are willing to take part can also join. Participants in the recovery-oriented group will work with their treatment professionals to set goals and monitor their recovery journey. This trial is not yet recruiting, but it aims to improve how care is provided to individuals with severe mental illness by focusing on their personal growth and wellbeing.
Gender
ALL
Eligibility criteria
- The study population will include:
- Patients with a mental disorder inclusion criteria:
- • diagnosis of a mental disorder according to DSM5TR,
- • receiving treatment at an SRP of the recruiting centers,
- * over 18 years old, willing to participate exclusion criteria:
- • moderate/severe intellectual disability,
- • inability to speak and write in Italian.
- Informal caregivers of patients inclusion criteria:
- • over 18 years old,
- * willing to participate, exclusion criteria:
- • inability to speak and write in Italian.
- Mental health professionals inclusion criteria:
- • working in SRPs of the recruiting centers as a psychiatrist, educator, nurse, social worker, OSS, ASA, or TeRP,
- * if part of the "personal recovery-oriented treatment" group, having specific training, exclusion criteria:
- • unwillingness to participate.
About Irccs Centro San Giovanni Di Dio Fatebenefratelli
IRCCS Centro San Giovanni di Dio Fatebenefratelli is a leading research and clinical care institution in Italy, dedicated to advancing medical science and improving patient outcomes through innovative clinical trials. As a recognized IRCCS (Istituto di Ricovero e Cura a Carattere Scientifica), the center emphasizes a multidisciplinary approach, integrating cutting-edge research with comprehensive healthcare services. With a strong commitment to ethical standards and patient safety, the institution collaborates with various stakeholders to foster advancements in medical knowledge and therapeutic practices, ultimately enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Alessandra Martinelli, MD PhD
Principal Investigator
IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported